4//SEC Filing
Prasad Raju 4
Accession 0000950170-25-043973
CIK 0001674416other
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 5:35 PM ET
Size
8.8 KB
Accession
0000950170-25-043973
Insider Transaction Report
Form 4
Prasad Raju
Chief Financial Officer
Transactions
- Sale
Common Shares
2025-03-21$41.23/sh−2,197$90,582→ 16,767 total - Exercise/Conversion
Restricted Stock Units
2025-03-20−6,250→ 18,750 total→ Common Shares (6,250 underlying) - Exercise/Conversion
Common Shares
2025-03-20+6,250→ 18,964 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
- [F2]Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.
- [F3]This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0001968317
Filing Metadata
- Form type
- 4
- Filed
- Mar 23, 8:00 PM ET
- Accepted
- Mar 24, 5:35 PM ET
- Size
- 8.8 KB